Promoting Alcohol Treatment Engagement Post-hospitalization

Description

This study is a 3-arm randomized clinical trial to evaluate the effectiveness of hospital-initiated Alcohol Use Disorder treatment, involving a Brief Negotiated Interview (with referral and telephone booster) alone, BNI+facilitated provision of MAUD, BNI+facilitated provision of MAUD+CBT4CBT on AUD treatment engagement, alcohol use and healthcare utilization.

Conditions

Alcohol Use Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is a 3-arm randomized clinical trial to evaluate the effectiveness of hospital-initiated Alcohol Use Disorder treatment, involving a Brief Negotiated Interview (with referral and telephone booster) alone, BNI+facilitated provision of MAUD, BNI+facilitated provision of MAUD+CBT4CBT on AUD treatment engagement, alcohol use and healthcare utilization.

Promoting Alcohol Treatment Engagement Post-hospitalization With Brief Intervention, Medications and CBT4CBT: A Randomized Clinical Trial in a Diverse Patient Population.

Promoting Alcohol Treatment Engagement Post-hospitalization

Condition
Alcohol Use Disorder
Intervention / Treatment

-

Contacts and Locations

New Haven

Yale New Haven Hospital, New Haven, Connecticut, United States, 06510

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * hospitalized at Yale New Haven Hospital (YNHH)
  • * meet Diagnostic and Statistical Manual (DSM-5) criteria for a moderate to severe AUD (regardless of primary reason for hospitalization) consistent with clinical guidelines for MAUD initiation
  • * \>1 heavy drinking day by TLFB in 30 days prior to hospitalization
  • * willing to consider MAUD
  • * willing and able to be contacted for follow-up
  • * provide written informed consent
  • * have been engaged in formal AUD treatment in the past 30 days (i.e., excluding mutual help groups, such as Alcoholics Anonymous)
  • * meet DSM-5 criteria for untreated moderate to severe opioid use disorder
  • * self-reported or urine testing confirming pregnancy, nursing, or trying to conceive
  • * life-threatening or unstable medical, surgical, or psychiatric condition that prohibits study participation
  • * inability to provide \>1 collateral contact for a friend or family member
  • * anticipate being unable to return for follow-up assessments for any reason, such as travel, incarceration, planned procedure
  • * inability to understand English or Spanish.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Yale University,

E. Jennifer Edelman, MD, PRINCIPAL_INVESTIGATOR, Yale University

Brian Kiluk, PhD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2026-12